Investigation of Intranasal Oxytocin on Relapse Risk in Cocaine-dependent Patients.

NCT02255357 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

43

Enrollment

OTHER

Sponsor class

Conditions

Cocaine Dependence

Interventions

DRUG: Placebo
DRUG: Intranasal Oxytocin

Sponsor

New York State Psychiatric Institute